AMRX Financials
Amneal Pharmaceuticals, Inc. Class A Common Stock - Financial statements & key metrics
Stock Price
$17.72
Market Cap
$5.19B
P/E Ratio
1298.0
EPS
$0.01
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.79B
Gross Profit
-
Operating Income
-
Net Income
$-73.88M
EPS (Diluted)
$-0.38
Balance Sheet Highlights
Total Assets
$3.50B
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$110.55M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$295.10M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
11.9%
Net Margin
0.2%
ROE
-881.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AMRX revenue?
AMRX's most recent quarterly revenue was $2.79B. Annual revenue can be calculated by summing the four most recent quarters.
Is AMRX profitable?
AMRX reported a loss of $73.88M in the most recent quarter. The net profit margin is 0.2%.
What is AMRX market cap?
AMRX has a market capitalization of $5.19B, making it a mid-cap stock.
Does AMRX have debt?
View AMRX's balance sheet for debt information.
What is AMRX cash flow?
Cash flow data is available in the full financial statements.